Drugs / MTP-PE/MF59
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00000972 | ? → Apr 1992 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTP-PE/MF59 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000972 ↗ |
| Modality | Other / unclassified | “MTP-PE/MF59 is an adjuvant” NCT00000972 ↗ |